Table 3.
Follow-up |
||||
---|---|---|---|---|
Outcome | Baseline | IPT | 6 mo | 12 mo |
Proportion of condom-protected sex, mean (SD) | ||||
HIV/STD RR group | 0.44 (0.38) | 0.82 (0.28) | 0.75 (0.36) | 0.72 (0.38) |
HP group | 0.44 (0.40) | 0.55 (0.43) | 0.56 (0.43) | 0.56 (0.43) |
Consistent (100%) condom use, No. (%) | ||||
HIV/STD RR group | 29 (11.15) | 110 (42.31) | 94 (36.15) | 95 (36.54) |
HP group | 38 (13.82) | 75 (27.27) | 72 (26.18) | 73 (26.55) |
Unprotected sex, mean (SD) | ||||
HIV/STD RR group | 16.38 (23.66) | 2.80 (6.82) | 5.05 (20.75) | 5.92 (20.10) |
HP group | 14.82 (25.24) | 8.52 (24.59) | 8.03 (17.42) | 7.25 (15.22) |
Concurrent partners, No. (%) | ||||
HIV/STD RR group | 49 (18.85) | 39 (15.00) | 48 (18.46) | 67 (25.77) |
HP group | 49 (17.82) | 42 (15.27) | 47 (17.09) | 64 (23.27) |
Abbreviations: HIV/STD, human immunodeficiency virus/sexually transmitted disease; HP, health promotion; RR, risk reduction.